American Diabetes Association 83rd Scientific Sessions 2023

40 $

+ Include: 229 videos, size: 167 GB

+ Target Audience: endocrinologist

Description

+ Include: 229 videos, size: 167 GB

+ Target Audience: endocrinologist

+ Sample video: contact me for sample video

+ Information:

83rd Scientific Sessions Learning Objectives

The Scientific Sessions offers comprehensive educational programming covering the latest in the field of diabetes. The program is designed for physicians, scientists, researchers, nurses, dietitians, pharmacists, psychologists, and other health care professionals.

At the conclusion of this activity attendees will be able to:

  • Identify the 2023 ADA Standards of Care for classifying, diagnosing, preventing, and treating prediabetes and diabetes
  • Assess non-pharmacologic treatment options for individualizing treatment protocols for the management of hyperglycemia and hypoglycemia
  • Apply clinical decision-making tools to the assessment and treatment of the complications related to diabetes
  • Develop a more aggressive, effective, physiological, psychological, and behavioral treatment plan for patients with diabetes
  • Cite the research into current, emerging, and novel therapies for type 1 and type 2 diabetes
  • Discuss proven education strategies for increasing the impact of diabetes education with individual patients
  • Interpret the latest findings in the areas of epidemiology, genetics, immunology, transplantation, and islet biology as they relate to diabetes

Acute and Chronic Complications

Foot Care/Lower Extremities
Hypoglycemia
Lipids
Macrovascular Complications
Diabetic Kidney Disease
Neuropathy
Retinopathy

Behavioral Medicine, Clinical Nutrition, Education, and Exercise

Clinical Nutrition
Diabetes Education
Exercise
Psychosocial, Behavioral Medicine

Clinical Diabetes/Therapeutics

Health Care Delivery/Economics
Pregnancy
Clinical Therapeutics
New Technology
Youth

Epidemiology/Genetics

Epidemiology
Genetics and Gene Regulation

Immunology/Beta Cell Replacement

Immunology
Beta-Cell Replacement

Insulin Action/Molecular Metabolism

Insulin Action
Molecular Metabolism

Obesity/Integrated Physiology

Metabolism, In Vivo (Animals)
Metabolism, In Vivo (Humans)
Obesity/Pathogenesis of Obesity

Islet Biology/Insulin Secretion

Islet Biology
Insulin Secretion

 

 

 

 

 

+ Topics:

A 360-Degree Examination of Type 1 Diabetes From Patient Identification to Treatment and Prevention.ts
Able-Bodied Aging Physical Activity Considerations for Older Adults with Diabetes.ts
Above and Beyond the Regular Lipid Panel Are Additional Measurements Really Needed.ts
ADA Chief Executive Officer Remarks; President, Health Care & Education Address; and Outstanding Educator in Diabetes Award Lecture.ts
ADA Diabetes Care Symposium Social Determinants of Health Impact on Diabetes Development and Care.ts
ADA Diabetes Journal Symposium Staying in Network Adipocyte Communication in Regulation of Energy Balance.ts
ADA Education Recognition Program Impact in Pregnancy MOMs in Control of Diabetes.ts
ADA Symposium Major Advances and Discoveries in Diabetes The Year in Review.ts
Addressing Context to Facilitate Individualized Diabetes Management.ts
Adipose Thermogenesis and Body Weight Homeostasis.ts
Advances in Diagnosis and Novel Treatments for Diabetes in Pregnancy.ts
Advances in Incretin Therapy.ts
Aging-Related Metabolic Disease Major Drivers and Therapeutic Strategies.ts
All the Omics What Do They Tell Us about Diabetes.ts
Antiobesity and Antidiabetes Therapeutics Targets and Mechanistic Insights.ts
Are Two Better than One Initial Combination Therapy in Type 2 Diabetes Mellitus.ts
Art of Writing a Winning Grant.ts
Automated Insulin Delivery Use among Pregnant Women with Type 1 Diabetes Past, Present, and Future.ts
Balancing the Scale Addressing Diabetic Kidney Disease across the Lifespan through Weight Loss.ts
Bariatric Surgery and Beyond The Benefits of Battling Obesity.ts
Behavioral Markers of Diabetes Self-Management State of the Science and Measurement Controversies Honoring the Legacy of Mark Peyrot.ts
Behavioral Medicine and Psychosocial Factors Implicated in Type 1 Diabetes Outcomes.ts
Beta-Cell Identity from Prenatal Life to Death.ts
Beta-Cell Stress and Exit.ts
Beyond Antihyperglycemic and Antihypertensive Agents for Diabetic Kidney Disease.ts
Beyond Calories In, Calories Out in Treating Obesity.ts
Beyond the Scales Emerging Strategies to Improve Metabolic Outcomes for People with Obesity.ts
Cellular and Molecular Mechanisms of Type 1 Diabetes.ts
Cellular Cross Talk Regulating Insulin Action.ts
Chrononutrition for the Prevention and Treatment of Diabetes.ts
Clinical Cell Therapy for Diabetes.ts
Clinical Islet-Cell Transplantation.ts
Comparing Beta-Cell Replacement vs. Artificial Pancreas Smart Insulins with a Focus on New Innovations Untested Technologies.ts
Continuous Glucose Monitoring in Type 2 Diabetes Are We There Yet.ts
Controlling the Communicators Cytokine-Specific Therapies to Preserve Beta-Cell Function in Type 1 Diabetes.ts
COORDINATE Diabetes Study Results Symposium.ts
Creating a World without Visual Loss from Diabetes.ts
Cultivating Provider Resiliency and Preventing Burnout.ts
Cultivating Provider Resiliency.ts
Current Controversies in the Primary Prevention of Diabetes Macrovascular Complications.ts
Demystifying Device Data One Download at a Time.ts
Designer Beta Cells.ts
Diabetes Endotypes Defined by DNA.ts
Diabetes in the Child with Obesity.ts
Diabetes in the Hospital-Hospitalization, Early Consultation, and Optimizing Discharge.ts
Diabetes Is Costly across the Lifespan and around the World.ts
Diabetes Kidney Disease in Type 1 and Type 2 Diabetes The Same Disease.ts
Diabetes Treatment and the Kidney.ts
Diabetic Myopathy and Muscle Metabolism.ts
Discussion on Behavioral Markers of Diabetes Self-Management Perspectives from Clinicians and People with Diabetes.ts
Discussion on Clinical Centers and Programs.ts
Discussion on Diabetes and Cardiovascular Disease SGLT2 Inhibitors Innovative Research to Inform Clinical Practice.ts
Discussion on Diabetes in Primary Care.ts
Discussion on Diabetes in Youth.ts
Discussion on Diabetes Self-Management Education and Support.ts
Discussion on Diabetes Technology.ts
Discussion on Exercise Physiology Lactate Reimagined More than Just a Waste Product.ts
Discussion on Eye Health.ts
Discussion on Foot Care.ts
Discussion on Health Care Improvement Best Practices in Implementing ADA’s Standards of Care in Diabetes.ts
Discussion on Immunology, Immunogenetics, and Transplantation Engineering Islets and Dealing with the Immune System.ts
Discussion on Islet Biology Development and Function Alpha, Beta, and Delta Cells of the Islets More than Just Neighbors.ts
Discussion on Nutritional Sciences and Metabolism Novel Methods of Dietary Assessment.ts
Discussion on Pregnancy and Reproductive Health Metformin Use in Type 2 Diabetes during Pregnancy A Debate.ts
Discussion on Public Health and Epidemiology Have We Succeeded in Type 2 Diabetes Primary Prevention.ts
Discussion on Women’s Interprofessional Network of the ADA Amplifying Women’s Voices in the Diabetes Workforce A Panel Discussion.ts
Do Quality Improvement Efforts Reduce Health Care Disparities.ts
Do Triglycerides Contribute to Residual Cardiovascular Disease Risk in Diabetes.ts
Do-It-Yourself (DIY) vs. Commercial Closed-Loop Systems for Managing Type 1 Diabetes.ts
Doc, Is My GLP-1 Med Making My Sight Worse New Considerations in Management of Diabetic Retinopathy.ts
Dual-Incretin Duel.ts
Dyslipidemia in Diverse Patient Populations.ts
Early Diagnosis of Diabetes Cardiomyopathy What Can Be Done.ts
Early Intervention.ts
Early Type 1 Diabetes.ts
Efficacy, Engagement, and Sustainability of Dietary Management Options in Type 2 Diabetes Time for a Reappraisal.ts
Emerging Biomarkers and Omics Approaches to Predict Cardiovascular Risk in Diabetes.ts
Emerging Clinical Risk Factors That Predict Cardiovascular Disease in Type 2 Diabetes.ts
Emerging Techniques and Treatments in Diabetic Peripheral Neuropathy.ts
Empowering the Acute Care Team to Optimize Diabetes Care and Education.ts
Endoplasmic Reticulum (ER) Stressed-Out Beta Cells.ts
Engineering and Site Consideration for Cell Therapy.ts
Enigma No More Recent Discoveries in Diabetes Foot Management.ts
Environmental Impacts on Obesity and Its Treatment.ts
Evidence for Reaching Out to Overcome Barriers and Achieve Goals.ts
Evolving Perspectives in Hypercortisolism A Panel Discussion Presented by Corcept Therapeutics.ts
Exercise and Metabolic Health Insight from Animal Studies.ts
Exercise as Medicine Physical Activity for Preventing and Managing Diabetes Complications.ts
Expanding the Delivery and Perception of Clinicians Providing Diabetes Self-Management Education.ts
Extending Our Reach Using Technology and Clinical Collaborations to Improve Outcomes.ts
Factors beyond the Food in Clinical Nutrition Research.ts
Functional Characterization of Type 2 Diabetes Genetic Loci.ts
Genetics of Glucose Metabolism in Pregnancy.ts
Glucagon Fest.ts
Glucose Monitoring Technologies 1.ts
Glucose Monitoring Technologies 2.ts
Hepatic Regulation of Metabolism.ts
Heterogeneity in Type 1 Diabetes.ts
Hope or Hype Role of Microbiome in Obesity.ts
Hot Topics in Nutrition What’s the Evidence.ts
How Sex Shapes Metabolism and Glucose Homeostasis.ts
Hypoglycemia as a Quality Measure Rationale, Challenges, and Opportunities.ts
Hypoglycemia in Older Adults with Diabetes.ts
Hypoglycemia, Catecholamine, and the Heart.ts
Immigration and Diabetes Diabetes Risk, Prevention, and Management in a Changing American Landscape.ts
Implementation of Guideline-Directed Medical Therapy for Cardiometabolic Disease Emerging Multidisciplinary Initiatives.ts
Improving Inclusive Care in Pediatric Diabetes Clinics ADA Youth Strategies Committee Symposium.ts
Improving Outcomes for Adolescents with Type 2 Diabetes.ts
Inflammatory Signaling and Insulin Action.ts
Innovation Challenge.ts
Innovative Engineering Approaches to Improve Islet Beta-Cell Transplantation.ts
Innovative Psychosocial and Behavioral Medicine Interventions in Type 1 Diabetes.ts
Insights into Novel Determinants of Outcomes in Pregnancies Complicated by Hyperglycemia.ts
Insulin Delivery Technologies 1.ts
Insulin Delivery Technologies 2.ts
Insulin Secretion.ts
Interactive Case Studies AID Systems Which Setting Would You Change.ts
Interactive Case Studies Optimizing Diabetes Technology in Special Populations.ts
Interoception Conversations with Adipocytes.ts
Introducing Dexcom G7 Simplicity, Solutions, and Success for Your Patients and Your Practice Presented by Dexcom.ts
Is It All About the Food.ts
Is It Time to Revise Our Thinking on the Role of the K(ATP) Channel in Insulin Secretion.ts
Is Metabolic Surgery or Lifestyle Medical Management of Type 2 Diabetes Optimal for Long-Term Health.ts
Islet Endocrine Cells and Beta-Cell Surrogates.ts
It’s About Time Eating and Exercising in Metabolic Health.ts
Joint ADA AACC Symposium Hyperglycemia in the Hospital Are Our Tools for Measurement Accurate Enough.ts
Joint ADA ADCES Symposium Implementing Technology into a Busy Practice It Takes a Village.ts
Joint ADA ASN Symposium How Do We Address the Psychosocial Determinants of Health in Diabetes and Kidney Disease.ts
Joint ADA EASD Symposium Precision Medicine in Diabetes (PMDI).ts
Joint ADA ISPAD Symposium Why Aren’t All Guidelines the Same A Focused Review of Recommendations from ISPAD 2022 and ADA 2023.ts
Joint ADA JDRF Symposium Global Perspective on Population Level Type 1 Diabetes Screening and Monitoring.ts
Joint ADA The Lancet Symposium Global Inequity in Diabetes An International Perspective.ts
Kelly West Award for Outstanding Achievement in Epidemiology Lecture.ts
Learn How to Pitch Your Entrepreneurial Idea and Get Funding.ts
Let’s Talk about Sex.ts
Let’s Talk Treatment Discussing Options for Weight and Diabetes Management.ts
Management of the Athlete with Diabetes.ts
Managing Exercise in Type 1 Diabetes.ts
Managing NAFLD NASH in People with T2 Diabetes Disease Burden Diagnosis Current Emerging Armamentarium.ts
Mechanisms Linking Adipose Tissue to Dyslipidemia.ts
Metabolic Adaptation to Weight Loss in Humans.ts
Metabolic Effects of Dual Incretin Agonism.ts
Metabolic Liver Disease From Bench to Bedside.ts
Microbiome, Metabolome, Lipidome, Transcriptome, Proteome, and Genome Oh My Novel Insights from Omics-Based Biomarkers.ts
Mitochondrial Metabolism and Glucose Homeostasis.ts
Molecular and Cellular Pathways in Metabolic Control.ts
Molecular Metabolism.ts
More Than Weight Treating Obesity as Part of a Comprehensive Care Approach to Cardiometabolic Disease.ts
Moving Beyond HbA1c New Standards for Assessing Glycemic Control.ts
Moving beyond Simple Descriptions of Race Disparities Structural and Social Inequalities and Diabetes Outcome Disparities.ts
Multiancestry and Longitudinal Type 2 Diabetes Genetic Risk.ts
Multiancestry Genome-Wide Association Studies and Polygenic Risk Score.ts
Muscle Metabolism, Exercise, and Aging in Diabetes.ts
National Scientific & Health Care Achievement Awards Presentation and Outstanding Scientific Achievement Award Lecture.ts
New Breakthrough in Adipose-Tissue Biology.ts
New Insights in Epidemiology and Clinical Implications of Diabetic Neuropathy.ts
New Insights into Glucose and Metabolic Regulation.ts
New Progress in Defining Biological Mechanisms of Cardiovascular Risk and Protection in Diabetes.ts
New Treatment Possibilities for Cardiovascular Residual Risk in Diabetes.ts
NIDDK Early Career Investigator Symposium Behavioral and Physiological Adaptations to Optimize Glucose Control with Technology.ts
Novel Approaches to Characterization and Treatment of Diabetes in Pregnancy.ts
Novel Insights into Islet Development.ts
Nutrient-Stimulated Hormones Anti-Obesity Pharmacotherapy Game Changers.ts
Nutrition and Technology for Diabetes Management and Remission.ts
Nutrition in Pregnancy Is Low-Carb a No-Go.ts
Obesity and Metabolic Disease A Focus on Females.ts
Observing Metabolism through New Lenses.ts
Of Mice and Men Insights into Diabetic Retinopathy.ts
Only Time Will Tell Early Eating or Just Eating.ts
Oral Semaglutide for Treatment of Obesity and Type 2 Diabetes Results from OASIS 1 and PIONEER PLUS Trials.ts
Overcoming Barriers to Diabetes Technology.ts
Overcoming Therapeutic Inertia Leveraging the Diabetes Care Interprofessional Team.ts
Pathway to Stop Diabetes Symposium.ts
Prediabetes, Diabetes, and the Aging Brain.ts
President, Medicine & Science Address and Banting Medal for Scientific Achievement.ts
Preventing Diabetes Lessons Learned from Diabetes Prevention Programs.ts
Psychosocial Factors in Type 2 Diabetes Changing Individuals and Structural Barriers.ts
Real-Time Continuous Glucose MonitoringGoing Beyond the Obvious.ts
Real-World Data in Diabetes Research Promise or Peril.ts
Real-World Hypoglycemia in Older Adults with Diabetes.ts
Regulation of Insulin Signaling.ts
Remission or Bust.ts
Rescuing Islets in Type 1 Diabetes.ts
Retatrutide (LY3437943), a Novel GIP GLP-1 Glucagon Receptor Triagonist Obesity, NAFLD, and T2D Phase 2 Trial Results.ts
Retinopathy Risk Other Diseases, Devices, Disparities.ts
Risk Factors and Prevention of Hypoglycemia in People with Diabetes or after Bariatric Surgery.ts
SGLT Inhibition.ts
SGLT2i and GLP-1RA in Cardiovascular Disease An Update for Clinical Practice in 2023.ts
Should We Curb the Carbs.ts
Single-Cell RNAseq Revolution Decipher Metabolism One Cell at a Time.ts
Standardization of Person-Reported Outcomes (PROs) A Consensus Statement.ts
Stepping Ahead New Concepts in Diabetes Lower Extremities Complications.ts
Steps to Better Treating Type 1 Diabetes.ts
SURMOUNT 2 Trial Results and Potential Role of Tirzepatide in Treating Obesity in Type 2 Diabetes.ts
Technology or Immunomodulation The Best Course for Management of Type 1 Diabetes.ts
The Evolving Clinical Spectrum of Diabetic Neuropathy.ts
The Future Is Now Artificial Intelligence and Diabetes Foot Disease.ts
The Goldilocks Paradigm of Physical Activity and the Foot in Persons with Diabetes.ts
The Heart of the Matter Cardiovascular Health during Pregnancy and Beyond.ts
The Importance of Weight Loss Quality in Obesity Treatment.ts
The Islet Neighborhood.ts
The Islet-Cell Interactome.ts
The Jekyll and Hyde of Inflammatory Signals in Islets.ts
The Kidneys on the Frontline Unraveling the Kidney’s Energetic Response to Hypoxia.ts
The Molecular Consequences of Obesity across Human Tissues.ts
The New Normal Perspectives on Treatment and Trials as Immunotherapies Enter the Type 1 Diabetes Clinical Landscape.ts
The NIDDK Diabetic Foot Consortium So People with Diabetes May Stand Firm.ts
The Ongoing Impact of the DCCT EDIC Study at 40 Years.ts
The Quest to Delay or Prevent Type 1 Diabetes Onset-Recent Interventional Trials.ts
The Road Less Traveled U.S. Rurality and Diabetes.ts
Time-in-Range Where Are We Headed in 2023.ts
To Eat or Not to Eat Fasted vs. Postprandial Exercise for Glycemic Management.ts
Transforming Therapy with Ultra-Long-Acting Insulins.ts
Translating Psychosocial Care into Real-World Practice Settings.ts
Treatments New and Old.ts
Twitter Bugs Dancing between the Carbohydrate-Insulin, and Energy Balance Models.ts
Type 1 Diabetes Genetic Risk and Mechanisms.ts
Type 1 Diabetes through Another Lens Lessons from Other Disease Settings.ts
Type 2 Diabetes in Youth.ts
Unraveling Novel Regulators of Metabolism.ts
Updates in ADA’s Standards of Care in Diabetes 2023.ts
Updates in Diabetes and Fasting.ts
Welcome to Exosomes Their Role in Obesity.ts
Welcome to the 83rd ADA Scientific Sessions Keynote Address by Francis Collins MD, PhD and Panel Discussion.ts
What Can Diabetes Quality Teams Learn from Engineers and Designers.ts
What Is the Best Approach to the Management of Painful Diabetic Neuropathy.ts
What Is the Evidence That Lp(a) Is Significant in Diabetes Risk Assessment.ts
What’s the Verdict on Telehealth for Behavioral and Psychological Diabetes Care.ts
Where Lie the Keys to Type 2 Diabetes Prevention Population Health or Personalized Medicine.ts

Reviews

There are no reviews yet.

Be the first to review “American Diabetes Association 83rd Scientific Sessions 2023”

Your email address will not be published. Required fields are marked *